Should Methoxytyramine Routinely Be Included in the Guidelines for Biochemical Assessment of Pheochromocytomas and Paragangliomas?

Saved in:
Bibliographic Details
Main Authors: Ann T. Sweeney, MD, Michael A. Blake, MB, BCh, Sina Jasim, MD, MPH, Karel Pacak, MD, PhD, DSc
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060524001329
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841528041586556928
author Ann T. Sweeney, MD
Michael A. Blake, MB, BCh
Sina Jasim, MD, MPH
Karel Pacak, MD, PhD, DSc
author_facet Ann T. Sweeney, MD
Michael A. Blake, MB, BCh
Sina Jasim, MD, MPH
Karel Pacak, MD, PhD, DSc
author_sort Ann T. Sweeney, MD
collection DOAJ
format Article
id doaj-art-f8cebb120cbd4f94a3f4a892391a2e9f
institution Kabale University
issn 2376-0605
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series AACE Clinical Case Reports
spelling doaj-art-f8cebb120cbd4f94a3f4a892391a2e9f2025-01-15T04:11:46ZengElsevierAACE Clinical Case Reports2376-06052025-01-0111134Should Methoxytyramine Routinely Be Included in the Guidelines for Biochemical Assessment of Pheochromocytomas and Paragangliomas?Ann T. Sweeney, MD0Michael A. Blake, MB, BCh1Sina Jasim, MD, MPH2Karel Pacak, MD, PhD, DSc3Division of Endocrinology, Department of Medicine, St Elizabeth’s Medical Center, Brighton, MassachusettsDivision of Abdominal Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MassachusettsDivision of Endocrinology, Metabolism, and Lipid Research, Washington University in St, Louis, School of Medicine St. Louis, MissouriEunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Maryland; AKESO, Prague, Czech Republichttp://www.sciencedirect.com/science/article/pii/S2376060524001329
spellingShingle Ann T. Sweeney, MD
Michael A. Blake, MB, BCh
Sina Jasim, MD, MPH
Karel Pacak, MD, PhD, DSc
Should Methoxytyramine Routinely Be Included in the Guidelines for Biochemical Assessment of Pheochromocytomas and Paragangliomas?
AACE Clinical Case Reports
title Should Methoxytyramine Routinely Be Included in the Guidelines for Biochemical Assessment of Pheochromocytomas and Paragangliomas?
title_full Should Methoxytyramine Routinely Be Included in the Guidelines for Biochemical Assessment of Pheochromocytomas and Paragangliomas?
title_fullStr Should Methoxytyramine Routinely Be Included in the Guidelines for Biochemical Assessment of Pheochromocytomas and Paragangliomas?
title_full_unstemmed Should Methoxytyramine Routinely Be Included in the Guidelines for Biochemical Assessment of Pheochromocytomas and Paragangliomas?
title_short Should Methoxytyramine Routinely Be Included in the Guidelines for Biochemical Assessment of Pheochromocytomas and Paragangliomas?
title_sort should methoxytyramine routinely be included in the guidelines for biochemical assessment of pheochromocytomas and paragangliomas
url http://www.sciencedirect.com/science/article/pii/S2376060524001329
work_keys_str_mv AT anntsweeneymd shouldmethoxytyramineroutinelybeincludedintheguidelinesforbiochemicalassessmentofpheochromocytomasandparagangliomas
AT michaelablakembbch shouldmethoxytyramineroutinelybeincludedintheguidelinesforbiochemicalassessmentofpheochromocytomasandparagangliomas
AT sinajasimmdmph shouldmethoxytyramineroutinelybeincludedintheguidelinesforbiochemicalassessmentofpheochromocytomasandparagangliomas
AT karelpacakmdphddsc shouldmethoxytyramineroutinelybeincludedintheguidelinesforbiochemicalassessmentofpheochromocytomasandparagangliomas